Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Homozygosity for the toll-like receptor 2 R753Q single-nucleotide polymorphism is a risk factor for cytomegalovirus disease after liver transplantation.

Kang SH, Abdel-Massih RC, Brown RA, Dierkhising RA, Kremers WK, Razonable RR.

J Infect Dis. 2012 Feb 15;205(4):639-46. doi: 10.1093/infdis/jir819. Epub 2012 Jan 4.

2.

Relationship between Toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation.

Kijpittayarit S, Eid AJ, Brown RA, Paya CV, Razonable RR.

Clin Infect Dis. 2007 May 15;44(10):1315-20. Epub 2007 Apr 11.

PMID:
17443468
3.

Relationship between toll-like receptor 2 Arg677Trp and Arg753Gln and toll-like receptor 4 Asp299Gly polymorphisms and cytomegalovirus infection.

Jabłońska A, Paradowska E, Studzińska M, Suski P, Nowakowska D, Wiśniewska-Ligier M, Woźniakowska-Gęsicka T, Wilczyński J, Leśnikowski ZJ.

Int J Infect Dis. 2014 Aug;25:11-5. doi: 10.1016/j.ijid.2014.04.001. Epub 2014 May 9.

4.

Toll-like receptor 2 polymorphism and Gram-positive bacterial infections after liver transplantation.

Lee SO, Brown RA, Kang SH, Abdel-Massih RC, Razonable RR.

Liver Transpl. 2011 Sep;17(9):1081-8. doi: 10.1002/lt.22327.

5.

R753Q single-nucleotide polymorphism impairs toll-like receptor 2 recognition of hepatitis C virus core and nonstructural 3 proteins.

Brown RA, Gralewski JH, Eid AJ, Knoll BM, Finberg RW, Razonable RR.

Transplantation. 2010 Apr 15;89(7):811-5. doi: 10.1097/TP.0b013e3181cbac18.

6.

Clinical significance of the single nucleotide polymorphism TLR2 R753Q in heart transplant recipients at risk for cytomegalovirus disease.

Schneider M, Matiqi T, Kundi M, Rieder FJ, Andreas M, Strassl R, Zuckermann A, Jungbauer C, Steininger C.

J Clin Virol. 2016 Nov;84:64-69. doi: 10.1016/j.jcv.2016.10.003. Epub 2016 Oct 4.

PMID:
27723526
7.

Functional assessment of Toll-like receptor 2 and its relevance in patients with Staphylococcus aureus infection of joint prosthesis.

El-Helou O, Berbari EF, Brown RA, Gralewski JH, Osmon DR, Razonable RR.

Hum Immunol. 2011 Jan;72(1):47-53. doi: 10.1016/j.humimm.2010.10.001. Epub 2010 Oct 28.

PMID:
20937339
8.

Association between toll-like receptor polymorphisms and the outcome of liver transplantation for chronic hepatitis C virus.

Eid AJ, Brown RA, Paya CV, Razonable RR.

Transplantation. 2007 Aug 27;84(4):511-6.

PMID:
17713436
9.

Mannose-binding lectin and ficolin-2 gene polymorphisms predispose to cytomegalovirus (re)infection after orthotopic liver transplantation.

de Rooij BJ, van der Beek MT, van Hoek B, Vossen AC, Rogier Ten Hove W, Roos A, Schaapherder AF, Porte RJ, van der Reijden JJ, Coenraad MJ, Hommes DW, Verspaget HW.

J Hepatol. 2011 Oct;55(4):800-7. doi: 10.1016/j.jhep.2011.01.039. Epub 2011 Feb 18.

PMID:
21334396
10.

Association of Toll-like receptor 2 Arg753Gln and Toll-like receptor 1 Ile602Ser single-nucleotide polymorphisms with leptospirosis in an Argentine population.

Cédola M, Chiani Y, Pretre G, Alberdi L, Vanasco B, Gómez RM.

Acta Trop. 2015 Jun;146:73-80. doi: 10.1016/j.actatropica.2015.03.007. Epub 2015 Mar 14.

PMID:
25784560
11.

Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience.

Wadhawan M, Gupta S, Goyal N, Vasudevan KR, Makki K, Dawar R, Sardana R, Lal N, Kumar A.

Liver Transpl. 2012 Dec;18(12):1448-55. doi: 10.1002/lt.23540.

12.

Risk factors for cytomegalovirus reactivation after liver transplantation: can pre-transplant cytomegalovirus antibody titers predict outcome?

Bruminhent J, Thongprayoon C, Dierkhising RA, Kremers WK, Theel ES, Razonable RR.

Liver Transpl. 2015 Apr;21(4):539-46. doi: 10.1002/lt.24078. Epub 2015 Mar 12.

13.

Association between individual and combined SNPs in genes related to innate immunity and incidence of CMV infection in seropositive kidney transplant recipients.

Fernández-Ruiz M, Corrales I, Arias M, Campistol JM, Giménez E, Crespo J, López-Oliva MO, Beneyto I, Martín-Moreno PL, Llamas-Fuente F, Gutiérrez A, García-Álvarez T, Guerra-Rodríguez R, Calvo N, Fernández-Rodríguez A, Tabernero-Romo JM, Navarro MD, Ramos-Verde A, Aguado JM, Navarro D; OPERA Study Group..

Am J Transplant. 2015 May;15(5):1323-35. doi: 10.1111/ajt.13107. Epub 2015 Mar 16.

14.

The presence of functionally relevant toll-like receptor polymorphisms does not significantly correlate with development or outcome of sepsis.

Ahmad-Nejad P, Denz C, Zimmer W, Wacker J, Bugert P, Weiss C, Quintel M, Neumaier M.

Genet Test Mol Biomarkers. 2011 Sep;15(9):645-51. doi: 10.1089/gtmb.2010.0258. Epub 2011 Jul 1.

PMID:
21721932
15.

Polymorphisms in TLR-2 are associated with congenital cytomegalovirus (CMV) infection but not with congenital CMV disease.

Taniguchi R, Koyano S, Suzutani T, Goishi K, Ito Y, Morioka I, Oka A, Nakamura H, Yamada H, Igarashi T, Inoue N.

Int J Infect Dis. 2013 Dec;17(12):e1092-7. doi: 10.1016/j.ijid.2013.06.004. Epub 2013 Jul 29.

16.

Low frequency of Toll-like receptors 2 and 4 gene polymorphisms in Mexican patients and their association with type 2 diabetes.

Maldonado-Bernal C, Trejo-de la O A, Sánchez-Contreras ME, Wacher-Rodarte N, Torres J, Cruz M.

Int J Immunogenet. 2011 Dec;38(6):519-23. doi: 10.1111/j.1744-313X.2011.01035.x. Epub 2011 Sep 9.

PMID:
21902816
17.

[Toll-like receptor 2 R753Q polymorphisms are associated with an increased risk of infective endocarditis].

Bustamante J, Tamayo E, Flórez S, Telleria JJ, Bustamante E, López J, San Román JA, Alvarez FJ.

Rev Esp Cardiol. 2011 Nov;64(11):1056-9. doi: 10.1016/j.recesp.2011.02.024. Epub 2011 Jul 23. Spanish.

18.

Immunomodulatory Function of Interleukin 28B during primary infection with cytomegalovirus.

Egli A, Levin A, Santer DM, Joyce M, O'Shea D, Thomas BS, Lisboa LF, Barakat K, Bhat R, Fischer KP, Houghton M, Tyrrell DL, Kumar D, Humar A.

J Infect Dis. 2014 Sep 1;210(5):717-27. doi: 10.1093/infdis/jiu144. Epub 2014 Mar 11.

PMID:
24620020
19.

Incidence and dynamics of active cytomegalovirus infection in allogeneic stem cell transplant patients according to single nucleotide polymorphisms in donor and recipient CCR5, MCP-1, IL-10, and TLR9 genes.

Corrales I, Giménez E, Solano C, Amat P, de la Cámara R, Nieto J, Garcia-Noblejas A, Navarro D.

J Med Virol. 2015 Feb;87(2):248-55. doi: 10.1002/jmv.24050. Epub 2014 Aug 17.

PMID:
25132583
20.

Association between genetic polymorphisms of Toll-like receptor 2 (TLR2) and schizophrenia in the Korean population.

Kang WS, Park JK, Lee SM, Kim SK, Park HJ, Kim JW.

Gene. 2013 Sep 10;526(2):182-6. doi: 10.1016/j.gene.2013.04.058. Epub 2013 Apr 30.

PMID:
23644137

Supplemental Content

Support Center